Human Reproduction Archives
https://www.humanreproductionarchives.com/article/doi/10.4322/hra.001417
Human Reproduction Archives
Research Article Gynecological Endocrinology

Uterine morphological changes induced by androgenic anabolic steroids

Eryck Holmes Alves da Silva, Igor Rafael Praxedes de Sales, Lucas Norberto de Oliveira, Expedito Silva do Nascimento Jr

Downloads: 16
Views: 2508

Abstract

Objectives: The aim of this study was to evaluate morphological alterations in uterus induced by the irrational use of Anabolic Androgenic Steroids (AAS), particularly Nandrolone decanoate (ND). Methods: This paper presents a retrospective study of scientific articles available in full and free electronic access, using the platform PubMed in Portuguese and English, that reviews the effects of isolated ND use on the uterus and reproductive parameters in experimental animals. Results: AAS besides causing various systemic effects, in certain experimental animals alters uterine histological patterns. Histological analysis of the uterus of rats treated with ND showed deleterious effects, i.e., vacuolization and edema of the endometrial stroma. Conclusions: Thus, we conclude that use of ND shows high reproductive risks and can cause both damages and irreversible physiological changes.

Keywords

nandrolone decanoate; reproduction; uterus; steroids.

References

1. Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 2006;5(2):182- 93. PMid:24259990.
<br/><br/>2. Fragkaki A, Angelis Y, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Steroids. 2009;74(2):172-97. PMid:19028512. http://dx.doi.org/10.1016/j.steroids.2008.10.016.
<br/><br/>3. Bahrke M, Yesalis C. Abuse of anabolic androgenic steroids and related substances in sport and exercise. Curr Opin Pharmacol. 2004;4(6):614-20. PMid:15525553. http://dx.doi.org/10.1016/j.coph.2004.05.006.
<br/><br/>4. Kicman A. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-21. PMid:18500378. http://dx.doi.org/10.1038/bjp.2008.165.
<br/><br/>5. Clarkson P, Thompson H. Drugs and Sport. Sports Med. 1997;24(6):366-84. PMid:9421862. http://dx.doi.org/10.2165/00007256-199724060-00003.
<br/><br/>6. Lise MLZ, Gama e Silva TS, Ferigolo M, Barros HM. Gama e Silva TS da, Ferigolo M, Barros HMT. O abuso de esteroides anabólicoandrogênicos em atletismo. Rev Assoc Med Bras. 1999;45(4):364-70. PMid:10752246.
<br/><br/>7. Cunha TS, Cunha NS, Moura MJCS, Marcondes FK. Esteroides anabólicos androgênicos e sua relação com a prática desportiva. Rev Bras Cienc Farm. 2004;40(2):165-79. http://dx.doi.org/10.1590/S1516-93322004000200005.
<br/><br/>8. Kutscher E, Lund B, Perry P. Anabolic steroids. Sports Med. 2002;32(5):285-96. PMid:11929356. http://dx.doi.org/10.2165/00007256-200232050-00001.
<br/><br/>9. Ichihara I, Kawamura H, Nakano T, Pelliniemi L. Ultrastructural, morphometric, and hormonal analysis of the effets of testosterone treatment on leydig cells and other interstitial cells in young adult rats. Annals of Anatomy - Anat Anz. 2001;183(5):413-26. http://dx.doi.org/10.1016/S0940-9602(01)80196-5.
<br/><br/>10. Perry P, Lund B, Deninger M, Kutscher E, Schneider J. Anabolic steroid use in weightlifters and bodybuilders. Clin J Sport Med. 2005;15(5):326-30. PMid:16162991. http://dx.doi.org/10.1097/01.jsm.0000180872.22426.bb.
<br/><br/>11. Silva P, Machado Júnior L, Figueiredo V, Cioffi A, Prestes M, Czepielewski M. Prevalência do uso de agentes anabólicos em praticantes de musculação de Porto Alegre. Arq Bras Endocrinol Metabol. 2007;51(1):104-10. PMid:17435863. http://dx.doi.org/10.1590/S0004-27302007000100017.
<br/><br/>12. Obasanjo I, Cline J, Schmotzer S, Weaver D. Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques. Menopause. 1998;3(5):163-8. PMid:9774762. http://dx.doi.org/10.1097/00042192-199805030-00006.
<br/><br/>13. Basaria S, Wahlstrom J, Dobs A. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001;86(11):5108-17. PMid:11701661. http://dx.doi.org/10.1210/jcem.86.11.7983.
<br/><br/>14. Silva T, Frisoli Jr A, Pinheiro M, Szejnfeld V. Sarcopenia associada ao envelhecimento: aspectos etiológicos e opções terapêuticas. Rev Bras Reumatol. 2006;46(6) http://dx.doi.org/10.1590/S0482-50042006000600006.
<br/><br/>15. Rosenfeld R, France J, Attie K, Brasel J, Burstein S, Cara J, et al. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 1992;121(1):49-55. PMid:1625092. http://dx.doi.org/10.1016/S0022-3476(05)82540-5.
<br/><br/>16. Camargo ICC, Gênova TC, Machado MCP, Frei F, Mesquita SFP. Administração experimental de esteróide anabólico androgênico e álcool causa alterações histológicas e morfométricas nos ovários e útero de ratas adultas. Biosci J. 2011;27(4):656-65.
<br/><br/>17. Ferreira NAF, Sá SGV, Aleixo IB, Paiva AMR. Estudo dos efeitos provocados pelo uso do anabolizante estanozolol. Braz J Surg Clin Res. 2014;7(3):17-23.
<br/><br/>18. Hickson R, Ball K, Falduto M. Adverse effects of anabolic steroids. Med Toxicol. 1989;4(4):254-71. PMid:2671596. http://dx.doi.org/10.1007/BF03259912. 
<br/><br/>19. Chuffa LA, Souza R, Frei F, Mesquita SFP, Camargo I. Nandrolone decanoate and physical effort: histological and morphometrical assessment in adult rat uterus. Anat Rec. 2010;294(2):335-41. PMid:21235008. http://dx.doi.org/10.1002/ar.21314.
<br/><br/>20. Camargo I, Gaspar A, Frei F, Mesquita S. Efeitos dos esteroides anabólicos androgênicos sobre o útero e parâmetros reprodutivos de ratas adultas. Rev Bras Ginecol Obstet. 2009;31(9):453-60. PMid:19876577. http://dx.doi.org/10.1590/S0100-72032009000900006.
<br/><br/>21. Gerez J, Frei F, Camargo I. Histological assessment of ovaries and uterus of rats subjected to nandrolone decanoate treatment. Contraception. 2005;72(1):77-80. PMid:15964297. http://dx.doi.org/10.1016/j.contraception.2005.02.001.
<br/><br/>22. Clark A, Costine B, Jones B, Kelton-Rehkopf M, Meerts S, Nutbrown-Greene L, et al. Sex- and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res. 2006;1126(1):122-38. PMid:17010954. http://dx.doi.org/10.1016/j.brainres.2006.08.081.
<br/><br/>23. Camargo I, Leite G, Pinto T, Ribeiro-Paes J. Histopathologycal findings in the ovaries and uterus of albino female rats promoted by co-administration of synthetic steroids and nicotine. Exp Toxicol Pathol. 2014;66(4):195-202. PMid:24556002. http://dx.doi.org/10.1016/j.etp.2014.01.005.
<br/><br/>24. Belardin L, Simão V, Leite G, Chuffa L, Camargo I. Dose-dependent effects and reversibility of the injuries caused by nandrolone decanoate in uterine tissue and fertility of rats. Birth Defects Res B Dev Reprod Toxicol. 2014;101(2):168-77. PMid:24753332. http://dx.doi.org/10.1002/bdrb.21104.
<br/><br/>25. Wolf C, Hotchkiss A, Ostby JS, LeBlanc GA, Gray Jr LE. Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicol Sci. 2002;65(1):71-86. PMid:11752687. http://dx.doi.org/10.1093/ toxsci/65.1.71.
<br/><br/>26. Karbalay-Doust S, Noorafshan A. Stereological estimation of ovarian oocyte volume, surface area and number: application on mice treated with nandrolone decanoate. Folia Histochem Cytobiol. 2012;50(2):275-9. PMid:22763965. http://dx.doi.org/10.5603/FHC.2012.0037.
<br/><br/>27. Mobini Far H, Ågren G, Lindqvist A, Marmendal M, Fahlke C, Thiblin I. Administration of the anabolic androgenic steroid nandrolone decanoate to female rats causes alterations in the morphology of their uterus and a reduction in reproductive capacity. Eur J Obstet Gynecol Reprod Biol. 2007;131(2):189-97. PMid:16982131. http://dx.doi.org/10.1016/j.ejogrb.2006.07.037.
<br/><br/>28. Nieschlag E, Vorona E. MECHANISMS IN ENDOCRINOLOGY: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173(2):R47-58. PMid:25805894. http://dx.doi.org/10.1530/EJE-15-0080.
<br/><br/>29. Mertens H, Heineman M, Koudstaal J, Theunissen P, Evers J. Androgen receptor content in human endometrium. Eur J Obstet Gynecol Reprod Biol. 1996;70(1):11-3. PMid:9031911. http://dx.doi.org/10.1016/S0301-2115(96)02567-5.
<br/><br/>30. Kaeoket K, Persson E, Dalin A. The sow endometrium at different stages of the oestrous cycle: studies on morphological changes and infiltration by cells of the immune system. Anim Reprod Sci. 2001;65(1-2):95-114. PMid:11182512. http://dx.doi.org/10.1016/S0378-4320(00)00211-6.
<br/><br/>31. Jones R, Hannan N, Kaitu’u T, Zhang J, Salamonsen L. Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab. 2004;89(12):6155-67. PMid:15579772. http://dx.doi.org/10.1210/jc.2004-0507.

5a7c3a6c0e8825fc2fb51847 hra Articles
Links & Downloads

Hum Reprod Arch

Share this page
Page Sections